(Q45375655)

English

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

scientific article published in June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 December 2017

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers (English)

1 reference

Europe PubMed Central

13 December 2017

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Sharon R. Lewin

12

1 reference

Europe PubMed Central

13 December 2017

Kumar Visvanathan

13

1 reference

Europe PubMed Central

13 December 2017

Margaret Littlejohn

object named as

Margaret Littlejohn

6

0 references

author name string

Alexander J V Thompson

1

1 reference

Europe PubMed Central

13 December 2017

Tin Nguyen

2

1 reference

Europe PubMed Central

13 December 2017

David Iser

3

1 reference

Europe PubMed Central

13 December 2017

Anna Ayres

4

1 reference

Europe PubMed Central

13 December 2017

Kathy Jackson

5

1 reference

Europe PubMed Central

13 December 2017

John Slavin

7

1 reference

Europe PubMed Central

13 December 2017

Scott Bowden

8

1 reference

Europe PubMed Central

13 December 2017

Edward J Gane

9

1 reference

Europe PubMed Central

13 December 2017

William Abbott

10

1 reference

Europe PubMed Central

13 December 2017

George K K Lau

11

1 reference

Europe PubMed Central

13 December 2017

Paul V Desmond

14

1 reference

Europe PubMed Central

13 December 2017

Stephen A Locarnini

15

1 reference

Europe PubMed Central

13 December 2017

language of work or name

0 references

publication date

1 June 2010

1 reference

Europe PubMed Central

13 December 2017

1 reference

Europe PubMed Central

13 December 2017

51

1 reference

Europe PubMed Central

13 December 2017

6

1 reference

Europe PubMed Central

13 December 2017

1933-1944

1 reference

Europe PubMed Central

13 December 2017

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Viral dynamics in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Natural history of chronic hepatitis B virus infection: an immunopathological study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Correlation of hepatitis B core antigen and beta-catenin expression on hepatocytes in chronic hepatitis B virus infection: relevance to the severity of liver damage and viral replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Chronic hepatitis B: update 2009

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Integration of hepatitis B virus DNA into chromosomal DNA during acute hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoter

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Viral Quasi-Species Evolution During Hepatitis Be Antigen Seroconversion

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

21 January 2018

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring of antiviral therapy with quantitative evaluation of HBeAg: a comparison with HBV DNA testing

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23571

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.23571

1 reference

Europe PubMed Central

13 December 2017

1 reference

Europe PubMed Central

13 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45375655&oldid=2076246847"